Recently, the 49th annual Scientific Summit, hosted by the Kenya Medical Association, was held in the southwestern city of Eldoret. The theme of the summit is "Activating Healthcare System Transformation to Enhance physician well-being", which aims to discuss how to improve the local healthcare environment and clinical solutions to the threat of COVID-19. The summit was held simultaneously online and offline, with the participation of more than 500 doctors and scholars and top experts in the industry, and more than 30 well-known pharmaceutical manufacturers and chain pharmacy brands from international and local countries participated in the exhibition to discuss the development of health care and share the innovative achievements of the industry.
Physician Scholars attend the Annual Scientific Summit of the Kenya Medical Association
It is reported that the annual annual scientific summit of the Kenya Medical Association has been successfully held for forty-eight sessions, and the previous sessions have focused on hot issues in the local medical and health industry, which has effectively promoted international academic research exchanges and is of great value.
Innovative Chinese medicine Lianhua Qingpeng participated in the exhibition, attracting colleagues in the pharmaceutical industry
As an exhibitor of innovative Chinese medicines that debuted at the Kenya Medical Association's annual Science Summit, Yiling Pharmaceutical presented its R&D, production and registered capsules in Kenya to its pharmaceutical colleagues participating in the exhibition. As a patented proprietary Chinese medicine for treating colds, fighting influenza and playing an advantage in epidemic prevention and control, Lianhua Qingpeng capsules attracted the attention of doctors at the scene, and inquired about its efficacy and other information, and received trial samples. At the same time, the company has also made a concentrated display of its patented proprietary Chinese medicines in the field of cardiovascular and cerebrovascular diseases, such as macaroni capsules, Ginsengsong Yangxin capsules, alfalfa tonic capsules, and bazi kidney supplement capsules in the field of anti-aging.
The exhibitors introduced Lianhua Qing plague capsules to the Kenyan doctors in detail
Experts interpret the research evidence of Lianhua Qing plague
In the academic lecture session of the main venue, Dr. Okinyi David from Kisii Medical Training Institute in Kenya delivered an academic report entitled "Overview of the Research and Application of Respiratory Infectious Diseases in the Prevention and Treatment of Lianhua Qingpeng", which made a detailed interpretation of the current situation of respiratory infectious diseases, the clinical research of Lianhua Qingpeng in the treatment of influenza A(H1N1) influenza A and novel coronavirus pneumonia.
Dr. Okinyi David gave an academic lecture on Lianhua Qing plague in the main venue
At present, Lianhua Qingpeng has obtained registration approval or import license in nearly 30 countries and regions such as Brazil, Thailand, Ecuador, Singapore, Kenya, etc., of which the new crown indications have been approved in Kuwait; In Uzbekistan, the drug was included in the White List of Anti-epidemic Drugs of the Ministry of Health; In Thailand and Cambodia, they were admitted to designated hospitals for COVID-19 for the treatment of local patients; In July 2021, Lianhua Qingyi was selected as a home treatment plan for patients with mild COVID-19 issued by the Ministry of Health of Cambodia, becoming the first drug in China to enter the overseas COVID-19 treatment plan.